Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Bharat Immunological
Join Channel
Consolidated Standalone

Bharat Immunological

₹30.6 -0 | 0%

Market Cap ₹132 Cr.

Stock P/E -7.6

P/B -4.1

Current Price ₹30.6

Book Value ₹ -7.5

Face Value 10

52W High ₹43.9

Dividend Yield 0%

52W Low ₹ 20.5

Edit Ratio

Bharat Immunological Research see more...

Overview Inc. Year: 1989Industry: Pharmaceuticals & Drugs

Bharat Immunological Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Bharat Immunological Quarterly Results

#(Fig in Cr.) Sep 2020 Dec 2020 Jun 2021 Sep 2021 Dec 2021 Jun 2022 Sep 2022 Dec 2022 Jun 2023 Sep 2023
Net Sales 25 25 14 25 17 10 26 0 0 0
Other Income 0 1 0 0 0 0 0 0 0 0
Total Income 25 26 14 25 18 11 27 0 0 0
Total Expenditure 30 27 13 28 16 15 29 5 4 5
Operating Profit -4 -1 1 -3 1 -5 -2 -5 -4 -5
Interest 1 1 1 1 2 2 2 2 2 2
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -6 -2 0 -5 -0 -6 -4 -6 -6 -7
Provision for Tax -2 -1 -2 5 -0 -1 -1 -2 -1 -2
Profit After Tax -4 -2 2 -9 -0 -5 -3 -5 -5 -5
Adjustments 0 -0 0 -0 0 -0 0 0 -0 -0
Profit After Adjustments -4 -2 2 -9 -0 -5 -3 -5 -5 -5
Adjusted Earnings Per Share -0.9 -0.4 0.4 -2.2 -0.1 -1.2 -0.7 -1.1 -1.1 -1.1

Bharat Immunological Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 173 203 146 128 124 35 84 67 85 78 45 26
Other Income 1 6 1 1 1 1 4 1 2 1 1 0
Total Income 174 209 147 129 125 36 88 68 87 79 46 27
Total Expenditure 164 191 143 132 111 43 93 77 106 83 61 43
Operating Profit 10 18 4 -3 14 -7 -5 -9 -19 -4 -15 -16
Interest 2 6 1 6 4 1 2 5 5 6 7 8
Depreciation 1 1 1 1 1 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 7 11 2 -9 9 -8 -7 -14 -24 -10 -22 -23
Provision for Tax 2 5 1 -3 3 -4 -2 -4 -6 -1 -6 -6
Profit After Tax 5 6 2 -6 7 -4 -6 -10 -18 -9 -17 -18
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 5 6 2 -6 7 -4 -6 -10 -18 -9 -17 -18
Adjusted Earnings Per Share 1.2 1.5 0.4 -1.4 1.5 -1 -1.3 -2.4 -4.2 -2 -3.9 -4

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -42% -12% 5% -13%
Operating Profit CAGR 0% 0% 0% NAN%
PAT CAGR 0% 0% 0% NAN%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 34% -19% 30% 5%
ROE Average 0% -53% -43% -17%
ROCE Average -26% -36% -28% -5%

Bharat Immunological Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 42 40 41 35 42 37 31 20 34 105 88
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities -2 3 4 1 -1 -5 -4 -8 -14 -15 -20
Total Current Liabilities 45 48 35 30 14 13 88 101 64 101 94
Total Liabilities 85 91 80 66 55 45 115 113 84 192 162
Fixed Assets 8 7 6 5 5 5 5 4 4 116 116
Other Non-Current Assets 0 1 1 1 3 2 12 15 46 10 10
Total Current Assets 77 84 74 60 47 38 99 93 34 65 36
Total Assets 85 91 80 66 55 45 115 113 84 192 162

Bharat Immunological Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 10 41 23 30 20 0 1 0 1 1 5
Cash Flow from Operating Activities 31 -12 8 -9 -17 3 -32 34 12 -42 11
Cash Flow from Investing Activities 0 0 0 1 0 1 1 1 1 1 0
Cash Flow from Financing Activities -0 -6 -1 -2 -3 -3 31 -34 -12 45 -15
Net Cash Inflow / Outflow 31 -18 7 -10 -20 1 -1 1 0 3 -3
Closing Cash & Cash Equivalent 41 23 30 20 0 1 0 1 1 5 1

Bharat Immunological Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 1.16 1.48 0.36 -1.44 1.51 -0.99 -1.34 -2.36 -4.19 -2.03 -3.85
CEPS(Rs) 1.45 1.72 0.57 -1.29 1.64 -0.89 -1.28 -2.31 -4.14 -1.98 -3.81
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 9.72 9.21 9.57 8.13 9.67 8.68 7.1 4.74 0.55 -1.48 -5.33
Core EBITDA Margin(%) 5.34 5.89 2.33 -3.15 10.33 -22.78 -11.14 -15.56 -24.45 -6.34 -36.02
EBIT Margin(%) 5.24 8.4 2.2 -2.56 10.81 -19.97 -6.42 -14.14 -22.76 -5.21 -34.09
Pre Tax Margin(%) 3.97 5.42 1.43 -7 7.43 -22.87 -8.82 -21.25 -28.37 -12.36 -49.92
PAT Margin (%) 2.9 3.16 1.06 -4.85 5.24 -12.25 -6.93 -15.28 -21.23 -11.17 -37.3
Cash Profit Margin (%) 3.63 3.67 1.68 -4.34 5.71 -11.06 -6.6 -14.92 -20.95 -10.9 -36.85
ROA(%) 6.31 7.28 1.81 -8.5 10.8 -8.51 -7.22 -8.97 -18.41 -6.35 -9.41
ROE(%) 14.27 15.68 3.81 -16.25 16.94 -10.76 -17 -39.93 -158.64 0 0
ROCE(%) 23.51 42.29 9.07 -8.52 31.11 -17.52 -10.7 -21.87 -73.05 -8.08 -25.63
Receivable days 29.17 24.53 49.8 38.16 28.7 117.47 194 247.35 37.69 2.66 61.4
Inventory Days 54.73 55.72 69.3 68.59 33.57 10.98 35.26 180.65 139.46 115.8 154.12
Payable days 84.66 81.36 103.96 66.86 16.24 4.77 115.09 286.05 131.08 47.94 8.9
PER(x) 10.45 5.86 101.68 0 14.99 0 0 0 0 0 0
Price/Book(x) 1.25 0.94 3.8 2.27 2.34 2.27 1.08 1.23 83.21 -18.98 -4.16
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.06 0.06 0.81 0.54 0.47 1.87 0.69 0.24 2.5 2.38 3.53
EV/Core EBITDA(x) 1.07 0.72 28.54 -26.16 4.18 -9.96 -11.29 -1.74 -11.12 -48.1 -10.48
Net Sales Growth(%) 272.88 17.34 -27.88 -12.44 -3.01 -71.98 140.37 -20.1 27.68 -8.14 -43.09
EBIT Growth(%) 42.33 87.88 -81.08 -201.79 509.23 -151.74 22.72 -76.01 -105.48 78.97 -272.4
PAT Growth(%) -60.08 27.74 -75.87 -501.65 204.85 -165.46 -35.93 -76.27 -77.38 51.67 -90.08
EPS Growth(%) -60.08 27.74 -75.87 -501.66 204.85 -165.46 -35.93 -76.27 -77.38 51.67 -90.08
Debt/Equity(x) 0 -0.03 -0.21 0.27 0 0 1.05 0.15 11.56 -12.18 -3.05
Current Ratio(x) 1.71 1.73 2.08 2 3.31 3.05 1.12 0.92 0.53 0.65 0.38
Quick Ratio(x) 0.99 1.11 1.36 1.25 3.28 2.91 0.95 0.41 0.32 0.29 0.37
Interest Cover(x) 4.13 2.83 2.85 -0.58 3.19 -6.88 -2.68 -1.99 -4.06 -0.73 -2.15
Total Debt/Mcap(x) 0 -0.03 -0.06 0.12 0 0 0.97 0.12 0.14 0.64 0.73

Bharat Immunological Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at -4.1 times its book value
  • Debtor days have improved from 47.94 to 8.9days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of -53% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Bharat Immunological News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!